FacebookTwitterLinkedIn
here:scientific-publications:0
Read More

Pharmacokinetic and Dose-Finding Studies on Efpeglenatide in Patients With Type 2 Diabetes

Kun-Ho Yoon, Jahoon Kang, Se Chang Kwon, Michael E Trautmann, Marcus Hompesch, John Stewart, Christopher H Sorli
Diabetes Obes Metab . 2020 Aug;22(8):1292-1301. doi: 10.1111/dom.14032. Epub 2020 Apr 4.
here:scientific-publications:1
Read More

184 Insulin Sensitivity and Glucose Metabolism of Olanzapine and Combination Olanzapine and Samidorphan: A Phase 1 Exploratory Study in Healthy Volunteers

William Martin, Christine Graham, Linda Morrow, Carine Beysen, Frederico G S Toledo, Daiva Bajorunas, Ying Jian, Bernard Silverman, David McDonnell, Mark N Namchuk, John W Newcomer
CNS Spectr . 2020 Apr;25(2):316. doi: 10.1017/S1092852920000991.
here:scientific-publications:2
Read More

Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption

Powell DR, Zambrowicz B, Morrow L, Beysen C, Hompesch M, Turner S, Hellerstein M, Banks P, Strumph P, Lapuerta P
J Clin Endocrinol Metab. 2019 Dec 14. pii: dgz258. doi: 10.1210/clinem/dgz258.
here:scientific-publications:3
Read More

Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide

Rosenstock J, Sorli CH, Trautmann ME, Morales C, Wendisch U, Dailey G, Hompesch M, Choi IY, Kang J, Stewart J, Yoon KH
Diabetes Care. 2019 Jul 18. pii: dc182648. doi: 10.2337/dc18-2648. [Epub ahead of print]
here:scientific-publications:4
Read More

Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study

Pratley RE, Kang J, Trautmann ME, Hompesch M, Han O, Stewart J, Sorli CH, Jacob S, Yoon KH
Diabetes Obes Metab. 2019 Jul 2. doi: 10.1111/dom.13824. [Epub ahead of print]
here:scientific-publications:5
Read More

Sotagliflozin Decreases Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption

Powell D, Zambrowicz B, Morrow L, Beysen C, Hompesch M, Turner S, Hellerstein M, Banks P, Strumph P, Lapuerta P.
Presentation at the Endocrine Society Annual Meeting, New Orleans, LA. 2019 Mar 25.
here:scientific-publications:6
Read More

Pharmacokinetic and pharmacodynamic differences of new generation, longer-acting basal insulins: potential implications for clinical practice in type 2 diabetes

Hompesch M, Patel DK, LaSalle JR, Bolli GB
Postgrad Med. 2019 Jan 29. doi: 10.1080/00325481.2019.1568136.
here:scientific-publications:7
Read More

Relationship Between Controlled Attenuation Parameter (CAP) and Magnetic Resonance Imaging-Derived Proton Density Fat Fraction (MRI-PDFF) in Subjects at High Risk for Nonalcoholic Fatty Liver Disease (NAFLD)

Heidi Guthrie, Natalia Castro, Carine Beysen, Linda Morrow and Marcus Hompesch
Poster presented at the NASH-TAG Conference, Park City, UT. 2019 Jan 3-5.
here:scientific-publications:8
See More...
in cat NOT

Stay Connected

Would you like to receive updates from ProSciento?

I'm interested in receiving: